# A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

> **NCT07313917** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Longbio Pharma** · enrollment: 150 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

## Interventions

- **BIOLOGICAL:** LP-003 Injection
- **BIOLOGICAL:** Placebo of LP-003

## Key facts

- **NCT ID:** NCT07313917
- **Lead sponsor:** Longbio Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-09-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313917, "A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07313917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*